• In April 2026, LegalZoom and GoDaddy announced a partnership making LegalZoom the sole legal services provider within GoDaddy’s ecosystem, embedding LLC formation and compliance support directly into the GoDaddy customer journey.
• This deepened integration effectively turns GoDaddy into a more comprehensive launchpad for small businesses, potentially increasing the stickiness and perceived value of its platform for entrepreneurs.
• Next, we’ll explore how integrating LegalZoom’s LLC formation tools into GoDaddy’s ecosystem could influence the company’s existing investment narrative.

The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

GoDaddy Investment Narrative Recap

To own GoDaddy, you need to believe it can turn its domain foothold into a broader small business platform, lifting recurring, higher margin revenue while containing churn and competition from integrated rivals. The LegalZoom partnership fits that thesis by embedding legal formation directly into GoDaddy’s flow, which could support near term attach rate and ARPU catalysts. It does not materially alter the key risk that customers may still opt for rival all in one platforms or free tools.

Among recent moves, the redesigned GoDaddy mobile app is most relevant here, because it underscores the same ambition as the LegalZoom deal: keep entrepreneurs inside one unified, app first ecosystem where they register domains, build sites, manage marketing and now start legal entities. Both developments sit squarely in the core catalyst that higher product bundling and usage depth could support margins and earnings, even as competition and churn remain persistent watchpoints.

Yet beneath this ecosystem story, investors should be aware that rising competition from advanced AI tools and free alternatives could still...

GoDaddy's narrative projects $5.9 billion revenue and $1.3 billion earnings by 2028. This requires 7.7% yearly revenue growth and a roughly $0.5 billion earnings increase from $808.5 million today.

Uncover how GoDaddy's forecasts yield a $119.43 fair value, a 39% upside to its current price.

Exploring Other Perspectives

Before this news, the most optimistic analysts were already assuming revenue of about US$6,000,000,000 and earnings near US$1,300,000,000 by 2029, so this kind of integration could either reinforce or challenge those views depending on how you weigh the upside of deeper partner driven bundles against the risk that powerful AI tools outside GoDaddy keep eroding demand for traditional domains and hosting.

Explore 4 other fair value estimates on GoDaddy - why the stock might be worth just $117.67!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your GoDaddy research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free GoDaddy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate GoDaddy's overall financial health at a glance.

Searching For A Fresh Perspective?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 31 best rare earth metal stocks of the very few that mine this essential strategic resource.
• AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.